32.05
Schlusskurs vom Vortag:
$32.44
Offen:
$32.32
24-Stunden-Volumen:
101.42K
Relative Volume:
1.32
Marktkapitalisierung:
$458.29M
Einnahmen:
$138.20M
Nettoeinkommen (Verlust:
$5.52M
KGV:
84.34
EPS:
0.38
Netto-Cashflow:
$9.86M
1W Leistung:
+4.69%
1M Leistung:
+10.48%
6M Leistung:
-15.99%
1J Leistung:
-23.34%
Surmodics Inc Stock (SRDX) Company Profile
Firmenname
Surmodics Inc
Sektor
Branche
Telefon
(952) 500-7000
Adresse
9924 W 74TH ST, EDEN PRAIRIE, MN
Vergleichen Sie SRDX mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
SRDX
Surmodics Inc
|
32.05 | 456.22M | 138.20M | 5.52M | 9.86M | 0.38 |
![]()
ABT
Abbott Laboratories
|
125.64 | 218.92B | 43.11B | 13.98B | 6.66B | 7.98 |
![]()
BSX
Boston Scientific Corp
|
106.21 | 152.62B | 17.55B | 2.03B | 2.72B | 1.37 |
![]()
SYK
Stryker Corp
|
396.66 | 153.22B | 23.22B | 2.86B | 3.58B | 7.40 |
![]()
MDT
Medtronic Plc
|
92.32 | 117.89B | 33.54B | 4.66B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
75.80 | 45.12B | 5.54B | 4.18B | 623.10M | 7.00 |
Surmodics Inc Stock (SRDX) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-03-07 | Hochstufung | Lake Street | Hold → Buy |
2023-06-13 | Hochstufung | Needham | Hold → Buy |
2023-02-13 | Herabstufung | Needham | Buy → Hold |
2020-07-23 | Hochstufung | Needham | Hold → Buy |
2019-12-11 | Herabstufung | Needham | Buy → Hold |
2019-11-01 | Herabstufung | Lake Street | Buy → Hold |
2019-08-01 | Bestätigt | Needham | Buy |
2019-05-02 | Bestätigt | Lake Street | Buy |
2019-05-02 | Bestätigt | Needham | Buy |
2019-02-21 | Bestätigt | Needham | Buy |
2018-05-16 | Bestätigt | Needham | Buy |
2018-03-01 | Hochstufung | Sidoti | Neutral → Buy |
2018-02-28 | Bestätigt | Lake Street | Buy |
2018-02-28 | Eingeleitet | Needham | Buy |
2017-07-14 | Eingeleitet | Lake Street | Buy |
2016-11-21 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
2016-10-06 | Herabstufung | Sidoti | Buy → Neutral |
2016-05-03 | Bestätigt | Barrington Research | Outperform |
2015-08-06 | Bestätigt | Barrington Research | Outperform |
2015-03-27 | Eingeleitet | Dougherty & Company | Buy |
2014-02-25 | Eingeleitet | Laidlaw | Buy |
2013-08-01 | Hochstufung | Feltl & Co. | Buy → Strong Buy |
2012-11-12 | Bestätigt | Barrington Research | Outperform |
Alle ansehen
Surmodics Inc Aktie (SRDX) Neueste Nachrichten
(SRDX) Trading Report - news.stocktradersdaily.com
What analysts say about Surmodics Inc. stockDynamic investment growth - Autocar Professional
Is Surmodics Inc. a good long term investmentLightning-fast growth - Autocar Professional
Surmodics Inc. Stock Analysis and ForecastExceptional growth trajectory - jammulinksnews.com
What makes Surmodics Inc. stock price move sharplyBig Profit Small Risk Alerts - Newser
Minne InnoSurmodics adds to med-device portfolio with $39.9M acquisition of Vetex Medical - The Business Journals
What drives Surmodics Inc. stock priceConsistent wealth multiplication - Autocar Professional
How Surmodics Inc. stock performs during market volatilityFree Expert Investment Advice - Newser
Why Surmodics Inc. stock attracts strong analyst attentionBreakout Setup Scanner - Newser
Surmodics, Inc. (SRDX): A High-Risk, Low-Reward Play in a Weak Momentum and Overvalued Market - AInvest
Zacks Research Reduces Earnings Estimates for Surmodics - Defense World
Cybersecurity Incident at Surmodics Highlights Industry Vulnerabilities - Zenopa
Cyber ThreatsSurmodics confirms cyberattack, says critical systems restored as investigation continues - teiss
SurModics Faces Cyber Incident with IT Systems - TipRanks
Surmodics reports June cyber incident, restores critical IT systems - Investing.com
Surmodics, Inc.(NasdaqGS: SRDX) dropped from Russell 2000 Defensive Index - MarketScreener
Surmodics, Inc. (NASDAQ:SRDX) Shares Bought by Bank of America Corp DE - Defense World
Why Is SurModics (SRDX) Up 6% Since Last Earnings Report? - sharewise
Surmodics, Inc. (NASDAQ:SRDX) Shares Bought by Deutsche Bank AG - Defense World
Surmodics, Inc. (SRDX) Stock Analysis: Exploring a 47.46% Potential Upside in the Medical Devices Sector - DirectorsTalk Interviews
US FTC files amended complaint to block GTCR acquisition of Surmodics - MLex
Surmodics Shares Positive TRANSCEND Trial Results - Medical Product Outsourcing
Illinois and Minnesota AGs Join FTC’s Lawsuit Against Private Equity Firm - regulatoryoversight.com
Surmodics Reports First Quarter of Fiscal Year 2025 Financial Results - ADVFN
Equities Analysts Issue Forecasts for Surmodics Q2 Earnings - Defense World
Legal & General Group Plc Buys 880 Shares of Surmodics, Inc. (NASDAQ:SRDX) - Defense World
Zacks Research Weighs in on Surmodics FY2025 Earnings - Defense World
Are Options Traders Betting on a Big Move in Surmodics Stock? - Yahoo Finance
SRDX Stock Down Following Q2 Earnings Miss, Gross Margin Contracts - TradingView
SurModics: Fiscal Q2 Earnings Snapshot - New Haven Register
Finanzdaten der Surmodics Inc-Aktie (SRDX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Surmodics Inc-Aktie (SRDX) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
DANTZKER DAVID | Director |
Feb 13 '25 |
Option Exercise |
27.30 |
5,275 |
144,008 |
44,399 |
BEDOYA JOSE H | Director |
Feb 14 '25 |
Option Exercise |
27.30 |
5,275 |
144,008 |
34,232 |
KNIGHT SUSAN E | Director |
Jan 24 '25 |
Option Exercise |
27.30 |
7,358 |
200,873 |
42,506 |
Arens Timothy J. | Chief Financial Officer |
Nov 26 '24 |
Sale |
39.44 |
7,009 |
276,453 |
70,350 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):